Live
FierceBiotechBioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNSFierceBiotechBiopharma leaders rally behind Pazdur for FDA commissioner pick. But does he want the role?Promega BlogCharged Molecular Glues: The Molecular Trojan Horse That Slipped Past Biology’s Toughest BouncerClinical OMICsContact Lenses Show Promise for DepressionBioPharma DiveBiogen pushing tau drug forward despite Alzheimer’s study failureEndpoints NewsDegron, CREATE, TenNor raise capital; Cabaletta posts CAR-T dataEndpoints NewsAstraZeneca follows Merck with Phase 3 win in bladder cancerEndpoints NewsMacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attackFierceBiotechCreate Medicines fashions $122M fundraise for in vivo CAR-T dreamsBioPharma DiveWith new data, Regenxbio to seek FDA approval of Duchenne gene therapyEndpoints NewsHow Penn Medicine plans to use AI to train their doctorsFierceBiotechBiogen advances Alzheimer’s tau program despite midphase miss

Archive

Latest Oldest Clear
@TOFWERK CHINA
Total 1
Source TOFWERK CHINA
Query --